Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10?

Neuroscience Letters

Volumn 653, Issue , 2017, Pages 152-158

  Sajja, Ravi K ^a   Prasad, Shikha ^a   Tang, Suni ^a   Kaisar, Mohammad A ^a   Cucullo, Luca ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

ABCB10; db db mice; In vivo imaging; Leukocyte; Mitochondria; Oxidative stress

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B10; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ABCB10 PROTEIN, MOUSE; NFE2L2 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MONOCYTE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2;

EID: 85020018204     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2017.05.059     Document Type: Article

References (37)

1. Agca, C.A., Tuzcu, M., Hayirli, A., Sahin, K., Taurine ameliorates neuropathy via regulating NF-kappaB and Nrf2/HO-1 signaling cascades in diabetic rats. Food Chem. Toxicol. 71 (2014), 116–121.
2. Aggarwal, A., Khera, A., Singh, I., Sandhir, R., S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes. J. Neurochem. 132 (2015), 595–608.
3. Alfieri, A., Srivastava, S., Siow, R.C., Cash, D., Modo, M., Duchen, M.R., Fraser, P.A., Williams, S.C., Mann, G.E., Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. Free Radic. Biol. Med. 65 (2013), 1012–1022.
4. Alfieri, A., Srivastava, S., Siow, R.C., Modo, M., Fraser, P.A., Mann, G.E., Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J. Physiol. 589 (2011), 4125–4136.
5. Baluchnejadmojarad, T., Kiasalari, Z., Afshin-Majd, S., Ghasemi, Z., Roghani, M., S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase. Eur. J. Pharmacol. 794 (2017), 69–76.
6. Cerutti, C., Edwards, L.J., de Vries, H.E., Sharrack, B., Male, D.K., Romero, I.A., MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium. Sci. Rep., 7, 2017, 45284.
7. Dinkova-Kostova, A.T., Abramov, A.Y., The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 88 (2015), 179–188.
8. Fujihara, R., Chiba, Y., Nakagawa, T., Nishi, N., Murakami, R., Matsumoto, K., Kawauchi, M., Yamamoto, T., Ueno, M., Albumin microvascular leakage in brains with diabetes mellitus. Microsc. Res. Tech. 79 (2016), 833–837.
9. Goldwaser, E.L., Acharya, N.K., Sarkar, A., Godsey, G., Nagele, R.G., Breakdown of the cerebrovasculature and blood-Brain barrier: a mechanistic link between diabetes mellitus and alzheimer's disease. J. Alzheimers Dis. 54 (2016), 445–456.
10. Hawkins, B.T., Lundeen, T.F., Norwood, K.M., Brooks, H.L., Egleton, R.D., Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50 (2007), 202–211.
11. Holloway, P.M., Gillespie, S., Becker, F., Vital, S.A., Nguyen, V., Alexander, J.S., Evans, P.C., Gavins, F.N., Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways. Vascul. Pharmacol. 85 (2016), 29–38.
12. Horani, M.H., Mooradian, A.D., Effect of diabetes on the blood brain barrier. Curr. Pharm. Des. 9 (2003), 833–840.
13. Huber, J.D., VanGilder, R.L., Houser, K.A., Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H2660–2668.
14. Janelidze, S., Hertze, J., Nagga, K., Nilsson, K., Nilsson, C., Swedish Bio, F.S.G., Wennstrom, M., van Westen, D., Blennow, K., Zetterberg, H., Hansson, O., Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiol. Aging 51 (2017), 104–112.
15. Kowluru, R.A., Mishra, M., Epigenetic regulation of redox signaling in diabetic retinopathy: role of Nrf2. Free Radic. Biol. Med. 103 (2017), 155–164.
16. Kumari, R., Willing, L.B., Patel, S.D., Baskerville, K.A., Simpson, I.A., Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke. J. Neurochem. 119 (2011), 1029–1040.
17. Li, W., Maloney, R.E., Aw, T.Y., High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: implications for diabetic cerebral microvasculature. Redox Biol. 5 (2015), 80–90.
18. Liesa, M., Luptak, I., Qin, F., Hyde, B.B., Sahin, E., Siwik, D.A., Zhu, Z., Pimentel, D.R., Xu, X.J., Ruderman, N.B., Huffman, K.D., Doctrow, S.R., Richey, L., Colucci, W.S., Shirihai, O.S., Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion. Circulation 124 (2011), 806–813.
19. Liesa, M., Qiu, W., Shirihai, O.S., Mitochondrial ABC transporters function: the role of ABCB10 (ABC-me) as a novel player in cellular handling of reactive oxygen species. Biochim. Biophys. Acta 1823 (2012), 1945–1957.
20. Okouchi, M., Okayama, N., Alexander, J.S., Aw, T.Y., NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia- induced brain endothelial cell apoptosis. Curr. Neurovasc. Res. 3 (2006), 249–261.
21. Prasad, S., Sajja, R.K., Kaisar, M.A., Park, J.H., Villalba, H., Liles, T., Abbruscato, T., Cucullo, L., Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol. 12 (2017), 58–69.
22. Prasad, S., Sajja, R.K., Naik, P., Cucullo, L., Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil, 2, 2014, 125.
23. Sajja, R.K., Green, K.N., Cucullo, L., Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro. PLoS One, 10, 2015, e0122358.
24. Sajja, R.K., Prasad, S., Cucullo, L., Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS, 11, 2014, 8.
25. Salameh, T.S., Shah, G.N., Price, T.O., Hayden, M.R., Banks, W.A., Blood-brain barrier disruption and neurovascular unit dysfunction in diabetic mice: protection with the mitochondrial carbonic anhydrase inhibitor topiramate. J. Pharmacol. Exp. Ther. 359 (2016), 452–459.
26. Serlin, Y., Levy, J., Shalev, H., Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc. Psychiatry Neurol., 2011, 2011, 609202.
27. Sharma, A., Rizky, L., Stefanovic, N., Tate, M., Ritchie, R.H., Ward, K.W., de Haan, J.B., The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction. Cardiovasc. Diabetol., 16, 2017, 33.
28. Starr, J.M., Wardlaw, J., Ferguson, K., MacLullich, A., Deary, I.J., Marshall, I., Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 74 (2003), 70–76.
29. Stranahan, A.M., Hao, S., Dey, A., Yu, X., Baban, B., Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice. J. Cereb. Blood Flow Metab. 36 (2016), 2108–2121.
30. Wang, X., Campos, C.R., Peart, J.C., Smith, L.K., Boni, J.L., Cannon, R.E., Miller, D.S., Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers. J. Neurosci. 34 (2014), 8585–8593.
31. Warren, M.S., Zerangue, N., Woodford, K., Roberts, L.M., Tate, E.H., Feng, B., Li, C., Feuerstein, T.J., Gibbs, J., Smith, B., S.M. de Morais, W.J. Dower K.J. Koller, Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol. Res. 59 (2009), 404–413.
32. Weksler, B., Romero, I.A., Couraud, P.O., The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS, 10, 2013, 16.
33. Xu, Z., Zeng, W., Sun, J., Chen, W., Zhang, R., Yang, Z., Yao, Z., Wang, L., Song, L., Chen, Y., Zhang, Y., Wang, C., Gong, L., Wu, B., Wang, T., Zheng, J., Gao, F., The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus. Neuroimage, 2016.
34. Yamamoto, M., Arimura, H., Fukushige, T., Minami, K., Nishizawa, Y., Tanimoto, A., Kanekura, T., Nakagawa, M., Akiyama, S., Furukawa, T., Abcb10 role in heme biosynthesis in vivo: abcb10 knockout in mice causes anemia with protoporphyrin IX and iron accumulation. Mol. Cell. Biol. 34 (2014), 1077–1084.
35. Yano, M., ABCB10 depletion reduces unfolded protein response in mitochondria. Biochem. Biophys. Res. Commun. 486 (2017), 465–469.
36. Zhao, J., Moore, A.N., Redell, J.B., Dash, P.K., Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J. Neurosci. 27 (2007), 10240–10248.
37. Zheng, A., Li, H., Xu, J., Cao, K., Li, H., Pu, W., Yang, Z., Peng, Y., Long, J., Liu, J., Feng, Z., Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of db/db mice: role of AMP-activated protein kinase activation. Br. J. Nutr. 113 (2015), 1667–1676.